Medication info
Euruvastatin Tablet 10/20 mg

Euruvastatin Tablet 10/20 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Youyu Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP × 3]
Approval status
Active

MFDS item code 202004559 · Approved 2020.06.23 · Insurance code 644503180

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dosage range of this medicine is 10/5mg to 10/20mg daily. The recommended starting dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Youyu Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL cholesterol
  • increased Apo B protein
  • increased triglycerides
  • increased non-HDL cholesterol
  • decreased HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps control cholesterol and fat levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It particularly lowers total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol levels, which is known as 'good' cholesterol. This medication is used in conjunction with dietary therapy when dietary control alone is insufficient. It also plays a significant role in reducing the risk of atherosclerotic vascular disease associated with hypercholesterolemia. Prior to medication administration, it is essential to identify any other causes of dyslipidemia such as diabetes or hypothyroidism and treat them if necessary. This medication is used to safely and effectively improve blood lipid status.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dosage range of this medicine is 10/5mg to 10/20mg daily. The recommended starting dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Precautions

This medication may cause rhabdomyolysis, a rare but serious side effect that can lead to severe muscle problems; therefore, if serious muscle pain or weakness occurs, the patient should immediately inform their doctor. Patients at higher risk for muscle injury, such as those with severe infections, hypotension, major surgery, trauma, or electrolyte abnormalities, may need to temporarily discontinue or stop using this medication. It should not be administered to patients with certain diseases or drug allergies, liver disease, severe renal impairment, muscular disorders, or to women who are pregnant or breastfeeding. Moreover, high doses of this medication are prohibited for patients with a history of muscle disease, hypothyroidism, alcohol addiction, or certain ethnicities (Asian descent) that are at a high risk of muscle injury. This medication contains lactose and should not be given to patients with lactose intolerance. Patients who are alcoholics or have liver dysfunction must use this medication with caution and should undergo regular liver function tests and muscle-related tests. During treatment, if symptoms such as muscle pain, cramps, weakness, fatigue, fever, etc., occur, the patient must notify healthcare professionals immediately. If blood tests are necessary, they should check for signs of muscle damage. Liver enzyme levels may rise; therefore, liver function tests should be conducted before and during treatment to catch any liver damage signs early. This medication should not be administered to women who are pregnant or breastfeeding, and women of childbearing age should use appropriate contraception while taking this medication. The administration of this medication is restricted in children and the elderly, especially the elderly, as they are at higher risk for myopathy; hence caution is needed. This medication may interact with other drugs, so it is important to consult with healthcare professionals, especially when taken with cyclosporine, fibrate drugs, or warfarin. In case of overdose, there is no specific antidote, so symptomatic treatment and management through liver and muscle-related tests are necessary. This medication should be kept out of reach of children and not transferred to another container.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, elevated AST, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, chest pain, facial swelling, unusual feeling, drug intolerance, colon polyp, irritable bowel syndrome, esophagitis, dizziness, drowsiness, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, myositis, rhabdomyolysis, weakness, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, memory decline, forgetfulness, amnesia, memory disorder, confusion, severe muscle weakness, ocular myasthenia, increased CK, constipation, increased AST, weakness, joint pain, fatigue, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine, headache, abdominal pain, diarrhea, fatigue, pharyngitis, sinusitis, upper respiratory infection, arthralgia, low back pain, cough, anaphylaxis, erythema multiforme, cholelithiasis, cholecystitis, tremors, epigastric pain, vomiting, gastritis, xerostomia, discomfort in the epigastrium, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinitis, limb pain, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival hyperemia, renal failure, abnormal liver function, increased blood creatinine, elevated blood pressure, increased serum urea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it should be kept in a cool environment, avoiding excessively hot or cold places, ideally at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.